Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy

Cardiology

Volumn 107, Issue 2, 2007, Pages 81-86

  Ridjab, Denio ^a   Koch, Matthias ^a   Zabel, Markus ^a   Schultheiss, Heinz Peter ^a   Morguet, Andreas J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apical; Cardiac arrest; Giant negative T waves; Hypertrophic cardiomyopathy; Syncope

Indexed keywords

VERAPAMIL;

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; CAUCASIAN; DEFIBRILLATOR; ECHOCARDIOGRAPHY; HEART ARREST; HEART ARRHYTHMIA; HEART LEFT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; RESUSCITATION; SYNCOPE; T WAVE;

ADULT; ANTI-ARRHYTHMIA AGENTS; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; HEART ARREST; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; VERAPAMIL;

EID: 33847010121     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094147     Document Type: Article

References (35)

1. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y: Giant negative T wave inversion as a manifestation of asymmetric apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasonocardiotomographic study. Jpn Heart J 1976;17:611-629.
2. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K: Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44:401-412.
3. Kitaoka H, Doi Y, Casey SA, Hitomi N, Furuno T, Maron BJ: Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol 2003;92:1183-1186.
4. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG: Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1-83.
5. Chikamori T, Doi YL, Akizawa M, Yonezawa Y, Ozawa T, McKenna WJ: Comparison of clinical, morphological, and prognostic features in hypertrophic cardiomyopathy between Japanese and western patients. Clin Cardiol 1992;15:833-837.
6. Moro E, D'Angelo G, Nicolosi GL, Mimo R, Zanuttini R: Long-term evaluation of patients with apical hypertrophic cardiomyopathy. Correlation between quantitative echocardiographic assessment of apical hypertrophy and clinical-electrocardiographic findings. Eur Heart J 1995;16:210-217.
7. Cannan CR, Reeder GS, Bailey KR, Melton LJ, Gersh BJ: Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation 1995;92:2488-2495.
8. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H: Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:638-645.
9. Maron BJ: Apical hypertrophic cardiomyopathy: the continuing saga. J Am Coll Cardiol 1990;15:91-93.
10. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED: Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990;15:83-90.
11. Vacek JL, Davis WR, Bellinger RL, McKiernan TL: Apical hypertrophic cardiomyopathy in American patients. Am Heart J 1984;108:1501-1506.
12. Rovelli EG, Parenti F, Devizzi S: Apical hypertrophy cardiomyopathy of 'Japanese type' in a Western European person. Am J Cardiol 1986;57:358-359.
13. Steingo L, Dansky R, Pocock WA, Barlow JB: Apical hypertrophic nonobstructive cardiomyopathy. Am Heart J 1982;104:635-637.
14. Koga Y, Katoh A, Matsuyama K, et al: Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol 1995;26:1672-1678.
15. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J: Prognosis in hypertrophic cardiomyopathy. Role of age and clinical, electrocardiographic and haemodynamics features. Am J Cardiol 1981;47:532-538.
16. McKenna WJ, Franklin RCG, Nihoyannopoulos P, Robinson KC, Deanfield JE: Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11:147-153.
17. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995;26:1529-1536.
18. Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ: Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993;72:939-943.
19. Maron BJ, Bonow RO, Seshagiri TNR, Roberts WC, Epstein SE: Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982;49:1838-1848.
20. Kimura A, Harada H, Park JE, Nishi H, Satoh M, Takahashi M, Hiroi S, Sasocka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y: Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997;16:379-383.
21. Döhlemann C, Hebe J, Meitinger T, Vosberg H-P: Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the β-myosin heavy chain gene and cardiac arrest in childhood. Z Kardiol 2000;89:612-619.
22. Abinader EG, Rauchfleisch S, Naschitz J: Hypertrophic apical cardiomyopathy: a subtype of hypertrophic cardiomyopathy. Isr J Med Sci 1982;18:1005-1009.
23. Koga Y, Itaya K, Toshima H: Prognosis in hypertrophic cardiomyopathy. Am Heart J 1984;108:351-359.
24. Sakamoto T, Amano K, Hada Y, Tei C, Takenaka K, Hasegawa I, Takahashi T: Asymmetric apical hypertophy: ten years experience. Postgrad Med J 1986;62:567-570. 25 Abinader EG, Sharif D, Shefer A, Naschitz J: Novel insights into the natural history of apical hypertrophic cardiomyopathy during long-term follow-up. Isr Med Assoc J 2002;4:166-169.
25. Wilson P, Marks A, Rastegar H, Manolis AS, Estes NA 3rd: Apical hypertrophic cardiomyopathy presenting with sustained monomorphic ventricular tachycardia and electrocardiographic changes simulating coronary artery disease and left ventricular aneurysm. Clin Cardiol 1990;13:885-887.
26. Elliott PM, Sharma S, Varnava A: Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;33:1596-1601.
27. Maron BJ: Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Cardiol Rev 2002;10:173-181.
28. Zhu DWX, Sun H, Hill R: The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998;21:299-302.
29. Maron BJ: Hypertrophic cardiomyopathy. Lancet 1997;350:127-133.
30. Maron BJ, Shen W-K, Link MS, Epstein AE, Almqusit AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-373.
31. Spirito P, Seidman CE, McKenna WJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775-785.
32. Zack PM, Blausey WL: Symptomatic Japanese-type apical hypertrophic cardiomyopathy in a non-Asian patient: Favorable response to treatment with verapamil. Am Heart J 1994;128:613-616.
33. Rosing DR, Kent KM, Maron BJ, Epstein SE: Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation 1979;60:1208-1213.
34. Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE: Effects of verapamil on left ventricular systolic funtion and diastolic filling in patients with hypetrophic cardiomyopathy. Circulation 1981;64:787-796.
35. Hess OM, Murakami T, Krayenbuehl HP: Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation 1986;74:530-543.